Leonhard Stärk/LinkedIn
Nov 2, 2026, 02:56
Leonhard Stärk: The Future of Universal Donor-Free Red Blood Cells
Leonhard Stärk, Advisory Board Member at Studien Wirken, shared a post on LinkedIn:
“All about blood for me as former CEO of Bavarian Red Cross Blood Donation Service it is a highlight!
Meetings and important strategic talks with collaboration partners and supporters in Munich for our customer and friend Ari Gargir.
His company RedC Biotech Ltd., Caesarea (Israel) is working hard on enabling universal, donor-free red blood cells for life saving transfusions and advanced therapies on the basis of steam cells. It‘s not ‘artificial blood’ it‘s much better!
Munich MedTech is proud to support this innovative project.
In July, I had the chance to visit the labs of RedC Biotech Ltd.”
Stay updated with Hemostasis Today.
-
Nov 2, 2026, 02:45Marija Tashkovska: Advancing Transfusion Medicine Through Collaboration
-
Nov 2, 2026, 02:32Rachel Rosovsky: Pulmonary Embolism During Pregnancy and Postpartum
-
Nov 2, 2026, 02:26Jaromir Vajter: Bleeding Risks and Anticoagulation After ECPR
-
Nov 2, 2026, 02:13Maia Meier: 111 Kilometres on Skis to the South Pole
-
Nov 1, 2026, 23:49Austin Reese: Should Anticoagulation for AF Continue When Patients Move into Long-Term Care?
-
Nov 1, 2026, 23:43Abdelmonam Hagag: Mechanical Thrombectomy vs Anticoagulation in Acute Pulmonary Embolism New Meta Analysis
-
Nov 1, 2026, 23:38Ankur Garg: Safe Water and Nutrition as Economic Investments for LMIC Demographic Dividends
-
Nov 1, 2026, 23:30Ana Paula Tagliari: FIH Experience with Penumbra Lightning Flash 2.0 at TCT 2026
-
Nov 1, 2026, 23:13Abdul Muqtadir Abbas: The Hematology of Ebola Virus Pathophysiology Coagulopathy and Multiorgan Dysfunction